NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

First Citizens BancShares Eyes Big Acquisition to Jump Over $250 Billion Asset Mark

First Citizens BancShares, fresh off buying Silicon Valley Bank, is hunting for deals like a possible KeyCorp takeover to quickly surpass $250 billion in assets and handle tougher rules with more scale.

First Citizens BancShares Eyes Big Acquisition to Jump Over $250 Billion Asset Mark
Credit: Elijah Nouvelage/Bloomberg
Already have an account? Sign in.
Featured/ 02/20/2026 · 5:37 PM
KEY
/ Read more

Feed↓

FDA Approves BYSANTI (Milsaperidone) for Bipolar I & Schizophrenia
02/20/2026 · 6:29 PM

FDA Approves BYSANTI (Milsaperidone) for Bipolar I & Schizophrenia

Vanda Pharmaceuticals’ BYSANTI (milsaperidone) receives FDA approval as a new atypical antipsychotic for bipolar I manic/mixed episodes and schizophrenia in adults. Launch expected Q3 2026 with strong patent protection until 2044.

/ Subscriber only
OpenAI Scales Back AI Ambitions: $600 Billion Compute Target by 2030, Eyes $280 Billion
Featured/ 02/20/2026 · 5:59 PM

OpenAI Scales Back AI Ambitions: $600 Billion Compute Target by 2030, Eyes $280 Billion

OpenAI scales back its massive compute spending target to ~$600B by 2030 (from earlier $1.4T talk), eyes over $280B revenue, closes in on $100B+ funding round with Nvidia, Amazon, and more.

/ Subscriber only
FDA Grants Priority Review to MOLBREEVI for Autoimmune PAP
02/20/2026 · 5:21 PM

FDA Grants Priority Review to MOLBREEVI for Autoimmune PAP

Savara’s MOLBREEVI just got FDA Priority Review for autoimmune PAP. Possible U.S. approval in August 2026 and first-ever approved therapy in US & Europe.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe